Quanterix (NASDAQ:QTRX) Stock Rating Upgraded by The Goldman

Quanterix (NASDAQ:QTRX – Get Rating) was upgraded by The Goldman Sachs Group from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, The Fly reports. The brokerage currently has a $27.00 price objective on the stock, up from their previous price objective of $13.00. The Goldman Sachs Group’s price […]

Related Keywords

, Nasdaq , Goldman Sachs Group , Quanterix Corp , Platinum Investment Management Ltd , Custom Assay Development , Vanguard Group Inc , Quanterix Company Profile , Blackrock Inc , Frontier Capital Management Co , Simoa Accelerator Laboratory , Granahan Investment Management , Get Rating , Capital Management , Investment Management , Platinum Investment Management , Simoa Assay Kits , Analysis System , Custom Assay , Quanterix Daily , Quanterix , Nasdaq Qtrx , Qtrx , Medical , Upgrade , The Goldman Sachs Group Inc ,